Fuji Moves Astaxanthin Production Out of Hawaii
Fuji Chemical Industry Co. has shifted its commercial cultivation of astaxanthin source Haematococcus pluvialis from its facility in Hawaii to its Swedish facility.
Fuji Chemical Industry Co. has shifted its commercial cultivation of astaxanthin source Haematococcus pluvialis from its facility in Hawaii to its Swedish facility. The company says the decision was made to achieve “better product uniformity, operational efficiency, and ease of expansion.”
Fuji said that although both facilities were fully enclosed bio-systems, each equally producing high levels of astaxanthin, the “two technologies were different [and] consolidating operations into one of the two technologies would avoid duplication of effort and achieve operational efficiency.” It noted that the Swedish facility survived because it can be expanded rapidly.
The company is still considering pursuing algal development at the Hawaii location.
The Nutritional Outlook Podcast Episode 39: Nutritional Outlook's Ingredients to Watch in 2025
February 25th 2025In this episode, Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2025.
